AI BriefingChina Approves World's First Invasive Brain Chip 'NEO'
Key point
China has approved the world's first invasive brain chip, 'NEO,' which can also be used for purposes beyond clinical trials.
Details
China has approved NEO, the world's first invasive neurotechnology chip, and its use is permitted beyond clinical trials.
The device features a less-invasive design in which the sensor does not directly penetrate the cerebral cortex, which enabled its rapid approval. The target age range is patients between 18 and 60 years old.
NEO has already been included in China's medical insurance system, and the Chinese government is supporting the BCI (brain-computer interface) field as a key task in its national five-year plan. Meanwhile, the next project, Beinao-1, is under development with a target approval date of 2028.
This summary was generated automatically by AI. Check the original for the author's claims and context. Copyright belongs to the original author.
Our guide explains how the AI works. Report summary errors, attribution issues, or removal requests via Contact.
Related
Meta Unveils Infrastructure Lab Developing Next-Gen AI HardwareNext-Generation Memory Technologies Preparing for the Post-HBM Era: The Rise of Magnonics and Vertical FeRAM